Avantium Shares on 7 September 2026: Price, Range and Business Profile

On 7 September 2026, shares of Avantium N.V. traded at €5.26, up from a previous close of €4.92. The stock moved within a day range of €5.11 to €5.39, and its 52-week range was €4.77 to €11.40. Market capitalisation stood at €132.59 million, putting the company within reach of its 52-week low.

Avantium, formerly Avantium Holding B.V., is a Netherlands-based environmental research and development company. It develops chemical technologies and production processes to convert biobased raw materials into sustainable products. The company operates through three segments: Catalysis, Sustainable Chemistry and YXY.

The Catalysis segment provides R&D services and systems for chemical, refining and energy companies, using its Flowrence Technology Platform to design catalyst-testing solutions. Sustainable Chemistry is a portfolio of projects focused on converting biomass into chemical building blocks and plastic materials. YXY includes the Synvina joint venture with BASF SE and is used to convert plant-based sugars into chemical building blocks for plastics such as polyethylene furanoate, or PEF.

Investing.com's quoted data showed a 12-month average price target of €27.18, with a low estimate of €5.00 and a high estimate of €95.70. Three analysts recommended buying the stock and one recommended selling, producing an overall Buy rating and an implied upside of 416.73%. The source notes that such market data may be indicative rather than exact.

Why Avantium's Analyst Target Range and BASF Joint Venture Matter

A Wide Gap Between the Market Price and Analyst Optimism

At €5.26, Avantium is only about 10% above its 52-week low of €4.77 and roughly 54% below its 52-week high of €11.40. The average analyst target of €27.18 therefore implies a very large recovery from current levels. However, the low target of €5.00 is barely below the traded price, while the high target of €95.70 is more than 18 times the current quote. That unusually wide dispersion suggests analysts hold very different assumptions about the company's ability to commercialise its technology at scale.

YXY and the BASF Joint Venture Are the Core Value Question

The company has three segments, but YXY is the most consequential part of the equity story because it represents the direct route to plant-based PEF and includes the Synvina joint venture with BASF SE. The Catalysis segment offers a more service-based, potentially steadier revenue stream through its Flowrence platform, while Sustainable Chemistry remains a project portfolio. For investors, the key uncertainty is not the company's listed market price on any single day, but whether the YXY technology and BASF partnership can convert laboratory and pilot-stage potential into commercial volumes.

What the Avantium Data Points Mean for Investors

  • Price context: At €5.26, Avantium is about 10% above its 52-week low of €4.77 and roughly 54% below its 52-week high of €11.40.
  • Analyst range: The 12-month price targets spread from €5.00, slightly below the current quote, to €95.70, with an average of €27.18 and an implied upside of 416.73%. This is not a guaranteed return; the data source itself warns of high trading risk.
  • Business exposure: The YXY segment, through the Synvina joint venture with BASF, is the direct route for plant-based PEF. Investor assumptions about Avantium depend heavily on that partnership's execution rather than on today's listed price alone.